LynnMarieMalecMD

Oncology • Milwaukee, WI

Hematologic Oncology

Physician

Join to view full profile

Dr. Malec is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malec's full profile

Already have an account?

Office
9000 W Wisconsin Ave
Milwaukee, WI 53226
Phone+1 414-266-2420

Fax+1 414-266-6837

Education & Training

UPMC Medical EducationFellowship, Pediatric Hematology/Oncology, 2011 - 2014
UPMC Medical EducationResidency, Internal Medicine/Pediatrics, 2006 - 2010
University of Wisconsin School of Medicine & Public HealthClass of 2006

Certifications & Licensure

WI State Medical License 2016 - 2025
PA State Medical License 2006 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform Start of enrollment: 2020 Aug 01
Withdrawn
Phase 3
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors Start of enrollment: 2019 Jan 30
Completed
Phase 1, Phase 2
Roles: Contact

Publications & Presentations

PubMed

24 citations
Extended half‐life factor VIII for immune tolerance induction in haemophilia
Lynn M. Malec, Janna M. Journeycake, Margaret V. Ragni
Haemophilia. 2016-11-01
13 citations
Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database
Lynn M. Malec, Charity G. Moore, Jonathan G. Yabes, Jie Li, Margaret V. Ragni
Haemophilia. 2015-09-01
20 citations
The Impact of Extended Half‐Life Factor Concentrates on Prophylaxis for Severe Hemophilia in The United States
Lynn M. Malec, Dunlei Cheng, Char Witmer, Julie Jaffray, Peter A. Kouides
American Journal of Hematology. 2020-08-01

Abstracts/Posters

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Lynn M. Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database
Lynn M Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Weekly Efanesoctocog Alfa Effective Option for Preventing Bleeding Among Kids with Severe Hemophilia a: NEJMAugust 11th, 2024
Hemophilia: Novel Tx Also Cuts Bleeding in KidsJuly 23rd, 2024
Altuviiio Prevents Bleeds in Young Children with Severe Hem a: TrialJuly 23rd, 2024
Join now to see all